ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 214 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 1.55 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,594,000 | -47.6% | 61,766 | +8.5% | 0.01% | -57.1% |
| Q4 2020 | $3,044,000 | +57.1% | 56,947 | +21.2% | 0.01% | +27.3% |
| Q3 2020 | $1,938,000 | -4.2% | 46,985 | +12.6% | 0.01% | -8.3% |
| Q2 2020 | $2,022,000 | +137.0% | 41,713 | +9.9% | 0.01% | +200.0% |
| Q1 2018 | $853,000 | -26.7% | 37,947 | -1.7% | 0.00% | -33.3% |
| Q4 2017 | $1,163,000 | -18.7% | 38,615 | +1.8% | 0.01% | -14.3% |
| Q3 2017 | $1,430,000 | -34.7% | 37,950 | -51.6% | 0.01% | +16.7% |
| Q2 2017 | $2,190,000 | +62.6% | 78,490 | +100.3% | 0.01% | -25.0% |
| Q1 2017 | $1,347,000 | -12.2% | 39,192 | 0.0% | 0.01% | -11.1% |
| Q4 2016 | $1,534,000 | -32.1% | 39,192 | -44.8% | 0.01% | -35.7% |
| Q3 2016 | $2,259,000 | +5.5% | 71,001 | +7.6% | 0.01% | 0.0% |
| Q2 2016 | $2,142,000 | – | 65,989 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 563,200 | $16,243,000 | 9.48% |
| Avoro Capital Advisors LLC | 1,486,460 | $42,870,000 | 8.66% |
| Baker Brothers Advisors | 25,819,768 | $744,642,000 | 7.30% |
| SECTORAL ASSET MANAGEMENT INC | 1,176,543 | $33,932,000 | 3.76% |
| HARVEY CAPITAL MANAGEMENT INC | 251,825 | $7,262,000 | 3.38% |
| ACUTA CAPITAL PARTNERS, LLC | 300,000 | $8,652,000 | 3.22% |
| Palo Alto Investors LP | 1,532,030 | $44,184,000 | 2.52% |
| Ghost Tree Capital, LLC | 350,000 | $10,094,000 | 2.43% |
| EMORY UNIVERSITY | 76,121 | $2,195,000 | 2.16% |
| WEATHERBIE CAPITAL, LLC | 576,784 | $16,634,000 | 2.09% |